Effect of Injection Duration on Pain and Bruising Associated with Subcutaneous Enoxaparin

Effect of Injection Duration on Site-Pain Intensity and Bruising Associated with Subcutaneous Enoxaparin sodium in Acute Coronary Syndrome Patients Hospitalized at CCU in Afshar Hospital, Yazd

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201110267909N1

Enrollment

Registered

2011-12-05

Start date

2011-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bruising assossiated with injection. Superficial injury of unspecified body region

Interventions

Intervention 1: Subcutaneous injection of Enoxaparin-Na for 30 seconds in the right or left side of abdomen. Intervention 2: Subcutaneous injection of Enoxaparin-Na for 10 seconds in the right or left

Subcutaneous injection of Enoxaparin-Na for 30 seconds in the right or left side of abdomen

Subcutaneous injection of Enoxaparin-Na for 10 seconds in the right or left side of abdomen

Eligibility

Sex/Gender

All

Age

30 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 30 – 75 years old Patients with Acute coronary syndrome; Conscious; without scar and lesion on the site of injection; Non pregnant patients; No coagulating disease Exclusions criteria: Patient younger than 30 years old and older than 75 years old; Pregnant patients; Scar and lesion on the site of injection; Unconscious; Coagulating disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Injection site pain. Timepoint: Before injection and immediately after injection. Method of measurement: Visual Analogue Scale.;Bruising at injection site. Timepoint: 24 and 48 hours after injection. Method of measurement: per square millimeter.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Najari Varzaneh

Medical University of Shahid Sadoughi Yazd, School of Nursing and Midwifery

z.najari@ssu.ac.ir+98 35 1824 1751

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026